Gelibter, Alain J <br/><br/>
Are dose-finding studies still necessary when targeted therapy is associated with chemotherapy?  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Oct 2006 
 - 4668-9; author reply 4669 p.  digital 
<br/><br/> Publication Type: Comment; Letter 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2006.08.3576  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibiotics, Antineoplastic--pharmacology<br/>Antineoplastic Agents--adverse effects<br/>Capecitabine<br/>Clinical Trials as Topic--methods<br/>Cohort Studies<br/>Data Interpretation, Statistical<br/>Deoxycytidine--analogs & derivatives<br/>Erlotinib Hydrochloride<br/>Fluorouracil--analogs & derivatives<br/>Gastrointestinal Tract--drug effects<br/>Humans<br/>Middle Aged<br/>Neoplasms--drug therapy<br/>Protein Kinase Inhibitors--pharmacology<br/>Quinazolines--pharmacology<br/>Research Design